Literature DB >> 29255744

Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance?

Mariana Verdelho Machado1.   

Abstract

Entities:  

Keywords:  Chronic hepatic disease; Controlled attenuation parameter; Steatosis

Year:  2017        PMID： 29255744      PMCID： PMC5729960          DOI： 10.1159/000478944

Source DB:  PubMed          Journal:  GE Port J Gastroenterol        ISSN： 2387-1954


× No keyword cloud information.
  36 in total

1.  Impact of liver steatosis on response to pegylated interferon therapy in patients with chronic hepatitis B.

Authors:  Fehmi Ateş; Mehmet Yalnız; Saadet Alan
Journal:  World J Gastroenterol       Date:  2011-10-28       Impact factor: 5.742

Review 2.  A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care?

Authors:  Ebenezer T Oni; Arthur S Agatston; Michael J Blaha; Jonathan Fialkow; Ricardo Cury; Andrei Sposito; Raimund Erbel; Ron Blankstein; Ted Feldman; Mouaz H Al-Mallah; Raul D Santos; Matthew J Budoff; Khurram Nasir
Journal:  Atherosclerosis       Date:  2013-08-09       Impact factor: 5.162

Review 3.  Non-invasive diagnosis of hepatic steatosis.

Authors:  Christiane Stern; Laurent Castera
Journal:  Hepatol Int       Date:  2016-10-25       Impact factor: 6.047

4.  Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy.

Authors:  Magali Sasso; Stéphane Audière; Astrid Kemgang; Farid Gaouar; Christophe Corpechot; Olivier Chazouillères; Céline Fournier; Olivier Golsztejn; Stéphane Prince; Yves Menu; Laurent Sandrin; Véronique Miette
Journal:  Ultrasound Med Biol       Date:  2015-09-19       Impact factor: 2.998

5.  Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without.

Authors:  Chia-Ming Chu; Deng-Yn Lin; Yun-Fan Liaw
Journal:  Dig Dis Sci       Date:  2012-08-18       Impact factor: 3.199

Review 6.  Insulin resistance and steatosis in chronic hepatitis C.

Authors:  Mariana V Machado; Helena Cortez-Pinto
Journal:  Ann Hepatol       Date:  2009       Impact factor: 2.400

7.  Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis.

Authors:  Giovanni Targher; Christopher D Byrne; Amedeo Lonardo; Giacomo Zoppini; Corrado Barbui
Journal:  J Hepatol       Date:  2016-05-17       Impact factor: 25.083

8.  Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study.

Authors:  Pauliina Pisto; Merja Santaniemi; Risto Bloigu; Olavi Ukkola; Y Antero Kesäniemi
Journal:  BMJ Open       Date:  2014-03-20       Impact factor: 2.692

9.  The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease.

Authors:  Jeong In Lee; Min Chul Kim; Byung Sub Moon; Young Seok Song; Eun Na Han; Hyo Sun Lee; Yoonjeong Son; Jihyun Kim; Eun Jin Han; Hye Jeong Park; Se Eun Park; Cheol Young Park; Won Young Lee; Ki Won Oh; Sung Woo Park; Eun Jung Rhee
Journal:  Endocrinol Metab (Seoul)       Date:  2016-03

10.  Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease.

Authors:  Feng Shen; Rui-Dan Zheng; Jun-Ping Shi; Yu-Qiang Mi; Guo-Feng Chen; Xiqi Hu; Yong-Gang Liu; Xiao-Ying Wang; Qin Pan; Guang-Yu Chen; Jian-Neng Chen; Liang Xu; Rui-Nan Zhang; Lei-Ming Xu; Jian-Gao Fan
Journal:  Liver Int       Date:  2015-03-06       Impact factor: 5.828
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.